1. Home
  2. |Locations
  3. |Denver

Denver

Overview

Crowell & Moring's Denver office opened in 2021. The team represents clients ranging from emerging businesses advancing cutting-edge energy innovations to middle market and Fortune 100 companies in the health care, hospitality, food and beverage, agribusiness, technology, telecommunications, sports and entertainment, and manufacturing sectors.

Lawyers in the Denver office are skilled at guiding clients through sophisticated corporate transactions, including acquisitions, dispositions, mergers, going-private transactions, leveraged buy-outs, reorganizations, and joint ventures, as well as with respect to general corporate and complex commercial matters.  In addition, the group has significant emerging companies/venture capital experience. Denver office lawyers have also represented clients in the sports and entertainment industries  with regard to sales of ownership stakes in professional sports teams and execution of sponsorship and naming rights transactions.

The Denver team has deep complex commercial and regulatory litigation experience in areas such as contracts, intellectual property, business torts, false advertising, defense of government enforcement proceedings, class actions and products liability, and labor and employment in state and federal courts nationwide. They advise clients on new product launches, distribution, safety and risk management, labeling, and supply chain issues.

  • Click here to explore opportunities in the Denver office.

    Click here to explore opportunities in the Denver office.

  • Crowell’s Denver office is dedicated to making an impact in our community. More than half of our Denver office lawyers provide more than 45 hours of pro bono service per year, including working with Colorado Innocence Project. Since our office opening in October 2021, our lawyers and professional staff have volunteered in our community, served on local non-profit boards, and given to organizations like ACLU, Denver Metro Chamber Leadership Foundation, Denver Urban Debate League, InteRoots, Legal Aid Foundation of Colorado, Girl Scouts of Colorado, Colorado Legal Services, American Heart Association, Colorado Center on Law and Policy, Florence Crittenton, Special Olympics of Colorado, Colorado Coalition for the Homeless, and National Park Trust.

    Crowell’s Denver office is dedicated to making an impact in our community. More than half of our Denver office lawyers provide more than 45 hours of pro bono service per year, including working with Colorado Innocence Project. Since our office opening in October 2021, our lawyers and professional staff have volunteered in our community, served on local non-profit boards, and given to organizations like ACLU, Denver Metro Chamber Leadership Foundation, Denver Urban Debate League, InteRoots, Legal Aid Foundation of Colorado, Girl Scouts of Colorado, Colorado Legal Services, American Heart Association, Colorado Center on Law and Policy, Florence Crittenton, Special Olympics of Colorado, Colorado Coalition for the Homeless, and National Park Trust.

  • Our Denver office is committed to advancing diversity, equity, and inclusion within our team and the broader legal community. We work with organizations such as:

    • Center for Legal Inclusiveness, which serves the community by actively educating and supporting private and public sector legal organizations in their own individual campaigns to create cultures of inclusion;
    • Colorado Hispanic Bar Association, which is committed to the advancement of the Colorado Hispanic community by expanding the number of Latinos in the legal profession;
    • Colorado Pledge to Diversity, a paid summer clerkship program created for 1L diverse law students;
    • Colorado Women’s Bar Association, whose mission is to promote the advancement of women in the law and harness the power of the legal profession to protect and promote the welfare of all women; and
    • Latinas First Foundation, which is a critical Colorado support network for Latinas that has provided over 200 scholarships, as well as mentorship and networking opportunities, and honors Colorado Latina Trailblazers and Unsung Heroines.

    Our Denver office is committed to advancing diversity, equity, and inclusion within our team and the broader legal community. We work with organizations such as:

    • Center for Legal Inclusiveness, which serves the community by actively educating and supporting private and public sector legal organizations in their own individual campaigns to create cultures of inclusion;
    • Colorado Hispanic Bar Association, which is committed to the advancement of the Colorado Hispanic community by expanding the number of Latinos in the legal profession;
    • Colorado Pledge to Diversity, a paid summer clerkship program created for 1L diverse law students;
    • Colorado Women’s Bar Association, whose mission is to promote the advancement of women in the law and harness the power of the legal profession to protect and promote the welfare of all women; and
    • Latinas First Foundation, which is a critical Colorado support network for Latinas that has provided over 200 scholarships, as well as mentorship and networking opportunities, and honors Colorado Latina Trailblazers and Unsung Heroines.

Contact

Insights

Client Alert | 4 min read | 04.10.25

Hikma and Amici Curiae Ask Supreme Court to Revisit Induced Infringement by Generic “Skinny Labels”

In Amarin Pharma, Inc. v. Hikma Pharms. USA Inc., C.A. No. 20-1630 (D. Del.), brand manufacturer Amarin brought an induced infringement claim against Hikma’s generic icosapent ethyl product, which lists Amarin’s Vascepa® as the reference listed drug. Vascepa was originally approved by the U.S. Food and Drug Administration (“FDA”) to treat severe hypertriglyceridemia, and later, Amarin obtained patents and approval for Vascepa as a treatment to reduce cardiovascular risk in certain patient populations. Hikma’s Abbreviated New Drug Application (“ANDA”) for generic icosapent ethyl included a Section viii statement that Hikma was not seeking approval for the patented cardiovascular indication along with a “skinny label” that included only the indication for severe hypertriglyceridemia....

View All Insights

Insights

Client Alert | 4 min read | 04.10.25

Hikma and Amici Curiae Ask Supreme Court to Revisit Induced Infringement by Generic “Skinny Labels”

Client Alert | 12 min read | 04.03.25

CMS Issues Marketplace Integrity and Affordability Proposed Rule

Client Alert | 4 min read | 04.01.25

For Better or MORSE: Another Settlement Under DOJ’s Civil Cyber-Fraud Initiative

Client Alert | 2 min read | 03.31.25

Canadian CMMC? Canada Proposes Cyber Compliance Regime for Canadian Defense Suppliers
|

View All Insights

Professionals

View All Professionals

Insights

Client Alert | 4 min read | 04.10.25

Hikma and Amici Curiae Ask Supreme Court to Revisit Induced Infringement by Generic “Skinny Labels”

In Amarin Pharma, Inc. v. Hikma Pharms. USA Inc., C.A. No. 20-1630 (D. Del.), brand manufacturer Amarin brought an induced infringement claim against Hikma’s generic icosapent ethyl product, which lists Amarin’s Vascepa® as the reference listed drug. Vascepa was originally approved by the U.S. Food and Drug Administration (“FDA”) to treat severe hypertriglyceridemia, and later, Amarin obtained patents and approval for Vascepa as a treatment to reduce cardiovascular risk in certain patient populations. Hikma’s Abbreviated New Drug Application (“ANDA”) for generic icosapent ethyl included a Section viii statement that Hikma was not seeking approval for the patented cardiovascular indication along with a “skinny label” that included only the indication for severe hypertriglyceridemia....

View All Insights